SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-17-013568
Filing Date
2017-11-20
Accepted
2017-11-20 14:00:34
Documents
57
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 1253269
2 ex10-1.htm EX-10.1 17355
3 ex31-1.htm EX-31.1 18495
4 ex31-2.htm EX-31.2 18415
5 ex32-1.htm EX-32.1 8012
6 ex32-2.htm EX-32.2 8339
  Complete submission text file 0001493152-17-013568.txt   7588075

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE rspi-20170930.xml EX-101.INS 1401664
8 XBRL SCHEMA FILE rspi-20170930.xsd EX-101.SCH 82589
9 XBRL CALCULATION FILE rspi-20170930_cal.xml EX-101.CAL 48734
10 XBRL DEFINITION FILE rspi-20170930_def.xml EX-101.DEF 336934
11 XBRL LABEL FILE rspi-20170930_lab.xml EX-101.LAB 544747
12 XBRL PRESENTATION FILE rspi-20170930_pre.xml EX-101.PRE 403546
Mailing Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452
Business Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452 (201) 444-4947
RespireRx Pharmaceuticals Inc. (Filer) CIK: 0000849636 (see all company filings)

IRS No.: 330303583 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-16467 | Film No.: 171213420
SIC: 2834 Pharmaceutical Preparations